National trends in dyslipidemia prevalence, awareness, treatment, and control in South Korea from 2005 to 2022
Abstract Dyslipidemia has steadily increased in South Korea over the past two decades, emerging as a major public health concern and key risk factor for cardiovascular disease. Thus, our study aimed to investigate long-term trends in the prevalence, awareness, treatment, and control of dyslipidemia...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-00354-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849766924761694208 |
|---|---|
| author | Hyeseung Lee Seokjun Kim Yejun Son Soeun Kim Hyeon Jin Kim Hyesu Jo Jaeyu Park Kyeongmin Lee Hayeon Lee Jiseung Kang Selin Woo Sunyoung Kim Sang Youl Rhee Jiyoung Hwang Lee Smith Dong Keon Yon |
| author_facet | Hyeseung Lee Seokjun Kim Yejun Son Soeun Kim Hyeon Jin Kim Hyesu Jo Jaeyu Park Kyeongmin Lee Hayeon Lee Jiseung Kang Selin Woo Sunyoung Kim Sang Youl Rhee Jiyoung Hwang Lee Smith Dong Keon Yon |
| author_sort | Hyeseung Lee |
| collection | DOAJ |
| description | Abstract Dyslipidemia has steadily increased in South Korea over the past two decades, emerging as a major public health concern and key risk factor for cardiovascular disease. Thus, our study aimed to investigate long-term trends in the prevalence, awareness, treatment, and control of dyslipidemia in South Korea, including the COVID-19 pandemic. This study utilized data from nationally representative cross-sectional surveys conducted as part of the Korea National Health and Nutrition Examination Survey from 2005 to 2022, analyzing long-term trends of dyslipidemia among 98,396 individuals aged over 30. Weighted linear and binary logistic regression were performed to calculate the β coefficients, βdiff, and weighted odds ratios with 95% confidence intervals (CIs). Weighted odds ratios were computed for various socioeconomic groups using aggregated data from 2005 to 2022. The prevalence of dyslipidemia increased from 41.30% (95% CI 40.40–42.21) in 2005–2009 to 48.41% (47.36–49.47) in 2020–2022. Awareness increased from 17.87% (16.75–18.99) to 48.90% (47.34–50.47), treatment from 7.10% (6.39–7.80) to 38.19% (36.61–39.76), and control among prevalence from 6.49% (5.79–7.19) to 31.82% (30.33–33.32). Treatment (βdiff, 3.94 [1.97–5.92]) and control among prevalence (βdiff, 3.52 [1.67–5.38]) increased more rapidly during the pandemic. Higher odds of dyslipidemia were associated with male sex, older population, rural residence, high BMI, central adiposity, low education and income levels, smoking, and high-risk alcohol consumption. Lower odds of awareness, treatment, and control among individuals with dyslipidemia were associated with male sex, younger population, rural residence, higher education and income levels, smoking, and high-risk alcohol consumption. Over the past 18 years, the prevalence, awareness, treatment, and control of dyslipidemia have steadily increased, with persistent disparities among socioeconomic groups. |
| format | Article |
| id | doaj-art-e992282dde324928b77f63ec00a87881 |
| institution | DOAJ |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-e992282dde324928b77f63ec00a878812025-08-20T03:04:25ZengNature PortfolioScientific Reports2045-23222025-05-0115111710.1038/s41598-025-00354-2National trends in dyslipidemia prevalence, awareness, treatment, and control in South Korea from 2005 to 2022Hyeseung Lee0Seokjun Kim1Yejun Son2Soeun Kim3Hyeon Jin Kim4Hyesu Jo5Jaeyu Park6Kyeongmin Lee7Hayeon Lee8Jiseung Kang9Selin Woo10Sunyoung Kim11Sang Youl Rhee12Jiyoung Hwang13Lee Smith14Dong Keon Yon15Department of Medicine, Kyung Hee University College of MedicineDepartment of Medicine, Kyung Hee University College of MedicineCenter for Digital Health, Medical Science Research Institute, Kyung Hee University College of MedicineCenter for Digital Health, Medical Science Research Institute, Kyung Hee University College of MedicineCenter for Digital Health, Medical Science Research Institute, Kyung Hee University College of MedicineCenter for Digital Health, Medical Science Research Institute, Kyung Hee University College of MedicineCenter for Digital Health, Medical Science Research Institute, Kyung Hee University College of MedicineCenter for Digital Health, Medical Science Research Institute, Kyung Hee University College of MedicineCenter for Digital Health, Medical Science Research Institute, Kyung Hee University College of MedicineDivision of Sleep Medicine, Harvard Medical SchoolDepartment of Medicine, Kyung Hee University College of MedicineDepartment of Family Medicine, Kyung Hee University Medical Center, Kyung Hee University College of MedicineDepartment of Medicine, Kyung Hee University College of MedicineDepartment of Medicine, Kyung Hee University College of MedicineCentre for Health, Performance and Wellbeing, Anglia Ruskin UniversityDepartment of Medicine, Kyung Hee University College of MedicineAbstract Dyslipidemia has steadily increased in South Korea over the past two decades, emerging as a major public health concern and key risk factor for cardiovascular disease. Thus, our study aimed to investigate long-term trends in the prevalence, awareness, treatment, and control of dyslipidemia in South Korea, including the COVID-19 pandemic. This study utilized data from nationally representative cross-sectional surveys conducted as part of the Korea National Health and Nutrition Examination Survey from 2005 to 2022, analyzing long-term trends of dyslipidemia among 98,396 individuals aged over 30. Weighted linear and binary logistic regression were performed to calculate the β coefficients, βdiff, and weighted odds ratios with 95% confidence intervals (CIs). Weighted odds ratios were computed for various socioeconomic groups using aggregated data from 2005 to 2022. The prevalence of dyslipidemia increased from 41.30% (95% CI 40.40–42.21) in 2005–2009 to 48.41% (47.36–49.47) in 2020–2022. Awareness increased from 17.87% (16.75–18.99) to 48.90% (47.34–50.47), treatment from 7.10% (6.39–7.80) to 38.19% (36.61–39.76), and control among prevalence from 6.49% (5.79–7.19) to 31.82% (30.33–33.32). Treatment (βdiff, 3.94 [1.97–5.92]) and control among prevalence (βdiff, 3.52 [1.67–5.38]) increased more rapidly during the pandemic. Higher odds of dyslipidemia were associated with male sex, older population, rural residence, high BMI, central adiposity, low education and income levels, smoking, and high-risk alcohol consumption. Lower odds of awareness, treatment, and control among individuals with dyslipidemia were associated with male sex, younger population, rural residence, higher education and income levels, smoking, and high-risk alcohol consumption. Over the past 18 years, the prevalence, awareness, treatment, and control of dyslipidemia have steadily increased, with persistent disparities among socioeconomic groups.https://doi.org/10.1038/s41598-025-00354-2COVID-19PandemicDyslipidemiaPrevalenceSouth KoreaTrend |
| spellingShingle | Hyeseung Lee Seokjun Kim Yejun Son Soeun Kim Hyeon Jin Kim Hyesu Jo Jaeyu Park Kyeongmin Lee Hayeon Lee Jiseung Kang Selin Woo Sunyoung Kim Sang Youl Rhee Jiyoung Hwang Lee Smith Dong Keon Yon National trends in dyslipidemia prevalence, awareness, treatment, and control in South Korea from 2005 to 2022 Scientific Reports COVID-19 Pandemic Dyslipidemia Prevalence South Korea Trend |
| title | National trends in dyslipidemia prevalence, awareness, treatment, and control in South Korea from 2005 to 2022 |
| title_full | National trends in dyslipidemia prevalence, awareness, treatment, and control in South Korea from 2005 to 2022 |
| title_fullStr | National trends in dyslipidemia prevalence, awareness, treatment, and control in South Korea from 2005 to 2022 |
| title_full_unstemmed | National trends in dyslipidemia prevalence, awareness, treatment, and control in South Korea from 2005 to 2022 |
| title_short | National trends in dyslipidemia prevalence, awareness, treatment, and control in South Korea from 2005 to 2022 |
| title_sort | national trends in dyslipidemia prevalence awareness treatment and control in south korea from 2005 to 2022 |
| topic | COVID-19 Pandemic Dyslipidemia Prevalence South Korea Trend |
| url | https://doi.org/10.1038/s41598-025-00354-2 |
| work_keys_str_mv | AT hyeseunglee nationaltrendsindyslipidemiaprevalenceawarenesstreatmentandcontrolinsouthkoreafrom2005to2022 AT seokjunkim nationaltrendsindyslipidemiaprevalenceawarenesstreatmentandcontrolinsouthkoreafrom2005to2022 AT yejunson nationaltrendsindyslipidemiaprevalenceawarenesstreatmentandcontrolinsouthkoreafrom2005to2022 AT soeunkim nationaltrendsindyslipidemiaprevalenceawarenesstreatmentandcontrolinsouthkoreafrom2005to2022 AT hyeonjinkim nationaltrendsindyslipidemiaprevalenceawarenesstreatmentandcontrolinsouthkoreafrom2005to2022 AT hyesujo nationaltrendsindyslipidemiaprevalenceawarenesstreatmentandcontrolinsouthkoreafrom2005to2022 AT jaeyupark nationaltrendsindyslipidemiaprevalenceawarenesstreatmentandcontrolinsouthkoreafrom2005to2022 AT kyeongminlee nationaltrendsindyslipidemiaprevalenceawarenesstreatmentandcontrolinsouthkoreafrom2005to2022 AT hayeonlee nationaltrendsindyslipidemiaprevalenceawarenesstreatmentandcontrolinsouthkoreafrom2005to2022 AT jiseungkang nationaltrendsindyslipidemiaprevalenceawarenesstreatmentandcontrolinsouthkoreafrom2005to2022 AT selinwoo nationaltrendsindyslipidemiaprevalenceawarenesstreatmentandcontrolinsouthkoreafrom2005to2022 AT sunyoungkim nationaltrendsindyslipidemiaprevalenceawarenesstreatmentandcontrolinsouthkoreafrom2005to2022 AT sangyoulrhee nationaltrendsindyslipidemiaprevalenceawarenesstreatmentandcontrolinsouthkoreafrom2005to2022 AT jiyounghwang nationaltrendsindyslipidemiaprevalenceawarenesstreatmentandcontrolinsouthkoreafrom2005to2022 AT leesmith nationaltrendsindyslipidemiaprevalenceawarenesstreatmentandcontrolinsouthkoreafrom2005to2022 AT dongkeonyon nationaltrendsindyslipidemiaprevalenceawarenesstreatmentandcontrolinsouthkoreafrom2005to2022 |